Aradigm

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Aradigm and buy or sell other stocks, options, and ETFs commission-free!

About ARDMQ

Aradigm is an emerging specialty pharmaceutical company focused on the development and commercialization of a portfolio of drugs delivered by inhalation for the treatment of severe respiratory diseases by pulmonologists. The Company has product candidates addressing the treatment of bronchiectasis, cystic fibrosis, inhalation tularemia and anthrax infections, and smoking cessation. 

CEO
John M. Siebert, PhD
CEOJohn M. Siebert, PhD
Employees
Employees
Headquarters
Hayward, California
HeadquartersHayward, California
Founded
1991
Founded1991
Employees
Employees

ARDMQ Key Statistics

Market cap
702.90K
Market cap702.90K
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
19.67K
Average volume19.67K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.20
52 Week high$0.20
52 Week low
$0.016
52 Week low$0.016
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.